Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suhexiang pill observational study in acute ischemic stroke
ChiCTR2400079654Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of suhexiang pill in ischemic stroke, sponsored by Beijing University of Chinese Medicine. Primary endpoint: mRS score. Started Jan 2024; status: recruiting.
02
Drugs
suhexiang pill
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400079654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079654.